|
A-431 Cell Line
| Origin of place |
United States  |
| Model |
|
| Supplier |
Creative Biogene |
| Price |
$1 |
| Hits |
815 |
| Updated |
2/26/2026 |
|
| Organism |
Homo sapiens, human |
| Cell Line Description |
A-431 is a cell line that exhibits epithelial morphology and was isolated from the epidermis of an 85-year-old female patient with epidermoid carcinoma. When EGF binds to its receptor (EGFR) on the surface of A-431 cells, rapid tyrosine phosphorylation of the membrane protein occurs, initiating a series of intracellular signaling pathways. These pathways include the MAPK/ERK and PI3K/AKT pathways, which play key roles in regulating cell cycle progression, survival, and proliferation. EGFR stimulates cell proliferation at low concentrations, while at high concentrations it inhibits the growth of A-431 cells and induces their terminal differentiation. This dynamic response to EGFR emphasizes the utility of this cell line for exploring cell signaling pathways and the cell cycle in the context of cancer. In addition, A-431 cell-derived xenograft models are used to study tumor behavior in a living setting and to evaluate anticancer therapies. |
| Tissue |
Skin; Epidermis |
| Disease |
Epidermoid carcinoma |
https://www.creative-biogene.com/support/a-431-cell-line.html
bio-equip.cn
Creative Biogene
Creative Biogene provides kits, reagents, and services that help researchers explore questions about gene discovery, regulation, and function. Creative Biogene holds a leadership position in the global market and is committed to improving the human condition through biotechnology.
Creative Biogene is a US-based manufacturer and provider of genomics and proteomics products and services for academic and governmental research institutes, pharmaceutical and biotechnology industry.
Our Mission
To become the premier provider of innovative technologies, products, unique tools and services for research discoveries and product development in the areas of biological and biomedical research. Emphasis will be placed on the manufacture and distribution of genomics and proteomics based biological research reagent products of the highest possible quality, which include nucleic acid, protein and antibody based research reagent products and services.
|
|
|